🔎 Trials Near Me

Home › Heart Failure › Illinois

Heart Failure clinical trials in Illinois

44 studies for Heart Failure are looking for participants at sites in Illinois.

Cities in Illinois

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  • Northwest Heart Clinical Research, LLC, Arlington Heights
  • Illinois Masonic Hospital, Chicago
  • Chicago Medical Research, Hazel Crest
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06424288

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  • Northwest Heart Clinical Research, LLC, Arlington Heights
  • Chicago Medical Research, Hazel Crest
  • Clinical Investigation Specialists, Inc., Libertyville
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06935370

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

  • Northwestern University, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Sep 29, 2026 · NCT05873634

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

  • Northwestern University, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Sep 29, 2026 · NCT06517186

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Chicago
  • Research Site, Gurnee
  • Research Site, Melrose Park
  • and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Midwest Cardiovascular Institute, Naperville
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Chicago Medical Research LLC, Hazel Crest
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459

Alleviant ALLAY-HFrEF Study

  • Midwest Cardiovascular Institute, Naperville
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06812533

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Champaign
  • Research Site, Chicago
  • Research Site, Chicago
  • and 4 more
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Chicago
  • Research Site, Hazel Crest
  • Research Site, Peoria
  • and 1 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 11, 2026 · NCT06307652

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • CON-10021, Glenview, IL, Glenview
  • CON-10041, Island Lake, IL, Island Lake
  • CON-10025, Naperville, IL, Naperville
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Chicago, IL Investigative Site 10062, Chicago
  • Glenview, IL Investigative Site 10021, Glenview
  • Naperville, IL Investigative Site 10025, Naperville
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • Advocate Christ Medical Center, Chicago
  • Northwestern University, Chicago
  • University of Chicago, Chicago
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  • University of Chicago, Hinsdale
  • Midwest Cardiovascular Institute, Naperville
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07069738

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

  • Local Institution - 153, Peoria
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Methodist Medical Center of Illinois, Peoria
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 27, 2026 · NCT06793371

Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

  • Research Site, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07690436

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

  • University of Chicago, Chicago
  • Advocate IMMC, Chicago
  • Ascenscion Alexian Brothers, Elk Grove Village
Recruiting
Ages 21 and older · All sexes · Updated Aug 25, 2026 · NCT05677100

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingObservational study
Up to age 18 · All sexes · Updated Aug 25, 2026 · NCT06532890

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

  • Tenax Investigational Site, Chicago
  • Tenax Investigational Site, Chicago
  • Tenax Investigational Site, Mount Prospect
  • and 1 more
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Chicago Clinical Research Institute INC, Chicago
  • Univer Of Illinois at Chicago, Chicago
  • Eagle Clinical Research, Chicago
  • and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001

Alleviant ALLAY-HF Study

  • Midwest Cardiovascular Institute, Naperville
Recruiting
Ages 40 and older · All sexes · Updated Aug 14, 2026 · NCT05685303

Study of the Progression of Chronic Cardiovascular Conditions

  • Prolaio, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07420907

Cardiac Power Output in Cardiogenic Shock Patients

  • The University of Chicago, Chicago
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05700617

ELEVATE-HFpEF Clinical Study

  • The University of Chicago Medical Center, Chicago
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

  • Northwestern University, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT06526988

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • Advocate Health System, Downers Grove
  • Heart Care Centers of Illinois (HCCI), Palos Park
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • University of Chicago, Chicago
  • Advocate Health & Hospitals Corporation, Oakbrook Terrace
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

  • NMH Clinical Research Unit, Chicago
  • Northwestern Memorial HealthCare - Arkes Pavilion, Chicago
  • Northwestern Memorial HealthCare - Feinberg Pavilion, Chicago
  • and 4 more
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated May 27, 2026 · NCT06991257

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)

  • University of Chicago, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06641362

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • Advocate Good Samaritan, Downers Grove
  • Midwest Cardiovascular Institute (MCI), Naperville
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Northwestern University Feinberg School of Medicine, Chicago
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06217302

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

  • Northwestern Memorial Hospital, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT06895070

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

  • Northwestern University, Chicago
RecruitingObservational study
Ages 21 and older · All sexes · Updated Mar 18, 2026 · NCT07059962

His-Bundle Corrective Pacing in Heart Failure

  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Chicago, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT05265520

iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure

  • Rush University Medical Center, Chicago
  • University of Illinois Hospital & Health Sciences System, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT06205225

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

  • University of Chicago, Chicago
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Dec 16, 2025 · NCT06039176

Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure

  • Endotronix, Naperville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 19, 2025 · NCT06783335

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.